CLINICAL TRIALS PROFILE FOR VARIZIG
✉ Email this page to a colleague
All Clinical Trials for VARIZIG
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00338442 ↗ | Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection | Approved for marketing | Cangene Corporation | 2006-02-01 | This study is to assess VariZIGā¢ for the treatment of patients at risk for developing serious complications from chicken pox. | |
NCT06068608 ↗ | A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy | Not yet recruiting | Zhuhai Trinomab Pharmaceutical Co., Ltd. | Phase 1 | 2023-10-05 | The purpose of this clinical trial is to evaluate the safety and tolerability of TNM005 following a single dose by intramuscular (IM) administration in healthy adult subjects The main questions it aims to answer are:1. safety profileļ¼2. PK properties 3. PD properties |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VARIZIG
Condition Name
Clinical Trial Locations for VARIZIG
Trials by Country
Clinical Trial Progress for VARIZIG
Clinical Trial Phase
Clinical Trial Sponsors for VARIZIG
Sponsor Name